Literature DB >> 18379874

Regulation and function of cyclic GMP-mediated pathways in glial cells.

María Antonia Baltrons1, Mariela Susana Borán, Paula Pifarré, Agustina García.   

Abstract

A large body of evidence supports a role for the NO-cGMP-protein kinase G pathway in the regulation of synaptic transmission and plasticity, brain development and neuroprotection. Circumstantial evidence implicates natriuretic peptide-stimulated cGMP formation in the same CNS functions. In addition to neurons, both cGMP-mediated pathways are functional in glial cells and an increasing number of reports indicate that they may control important aspects of glial cell physiology relevant to neuronal function. In this article we briefly review the regulation of cGMP formation in glial cells and summarize recent evidence indicating that cGMP-mediated pathways can play important roles in astroglial and microglial function in normal and diseased brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379874     DOI: 10.1007/s11064-008-9681-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  74 in total

Review 1.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Isoforms of NO-sensitive guanylyl cyclase.

Authors:  Michael Russwurm; Doris Koesling
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 3.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

Review 4.  Repair and regeneration of functional synaptic connections: cellular and molecular interactions in the leech.

Authors:  Yuanli Duan; Joseph Panoff; Brian D Burrell; Christie L Sahley; Kenneth J Muller
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

5.  Regulation of nerve growth factor release by nitric oxide through cyclic GMP pathway in cortical glial cells.

Authors:  H Xiong; K Yamada; H Jourdi; M Kawamura; N Takei; D Han; T Nabeshima; H Nawa
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

Review 6.  Signals for the induction of nitric oxide synthase in astrocytes.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  Neurochem Int       Date:  2006-06-05       Impact factor: 3.921

7.  Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA.

Authors:  Carlos E Pedraza; María Antonia Baltrons; Michael T Heneka; Agustina García
Journal:  J Neuroimmunol       Date:  2003-11       Impact factor: 3.478

8.  Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells.

Authors:  María Antonia Baltrons; Carlos E Pedraza; Michael T Heneka; Agustina García
Journal:  Neurobiol Dis       Date:  2002-07       Impact factor: 5.996

9.  Up-regulation of microglial CD11b expression by nitric oxide.

Authors:  Avik Roy; Yiu K Fung; Xiaojuan Liu; Kalipada Pahan
Journal:  J Biol Chem       Date:  2006-03-20       Impact factor: 5.157

10.  The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells.

Authors:  Mariela Susana Borán; María Antonia Baltrons; Agustina García
Journal:  Glia       Date:  2008-03       Impact factor: 7.452

View more
  4 in total

Review 1.  New perspectives in cyclic nucleotide-mediated functions in the CNS: the emerging role of cyclic nucleotide-gated (CNG) channels.

Authors:  Maria Vittoria Podda; Claudio Grassi
Journal:  Pflugers Arch       Date:  2013-10-19       Impact factor: 3.657

2.  The D153del mutation in GNB3 gene causes tissue specific signalling patterns and an abnormal renal morphology in Rge chickens.

Authors:  Hemanth Tummala; Stewart Fleming; Paul M Hocking; Daniel Wehner; Zahid Naseem; Manir Ali; Christopher F Inglehearn; Nikolai Zhelev; Douglas H Lester
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

3.  CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Patrick Oeckl; Petra Steinacker; Stefan Lehnert; Sarah Jesse; Hans A Kretzschmar; Albert C Ludolph; Markus Otto; Boris Ferger
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

4.  Dysfunctional cGMP Signaling Leads to Age-Related Retinal Vascular Alterations and Astrocyte Remodeling in Mice.

Authors:  Joseph M Holden; Sara Al Hussein Al Awamlh; Louis-Philippe Croteau; Andrew M Boal; Tonia S Rex; Michael L Risner; David J Calkins; Lauren K Wareham
Journal:  Int J Mol Sci       Date:  2022-03-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.